PATENT CLAIM ANALYSIS

Application Number: 16100193
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["436", "060000"]

Abstract:
Compounds and methods for treating diseases mediated by a P2X 3  and/or a P2X 2/3  receptor antagonist, the methods comprising administering to a subject in need thereof an effective amount of a compound of formula (I): or a pharmaceutically acceptable salt, solvate or prodrug thereof, wherein X is O, D, Y, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7  and R 8  are as defined herein.

Claim (Index 6):
The compound of  claim 1 , wherein R 7 , R 8 , R d  and R e  are hydrogen.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 96.0
- Lexical Diversity: 1.49153
- Patent Class: 436.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14453409', '12963413', '11510015', '11071555', '13186078']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7823873712347458
- 35 USC 102 Novelty (BERT): 0.6266056626813017
- Combined Prediction Score: 0.7668092003794015
- Mean Citation Score: 492.4545719999999
- Max Citation Score: 590.0988
- Similarity Product: 586.5538913776875

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test